Literature DB >> 31371185

The role of infections in autoimmune encephalitides.

B Joubert1, J Dalmau2.   

Abstract

Autoimmune encephalitides are autoimmune neurological disorders characterized by rapidly progressive central nervous system symptoms associated with specific auto-antibodies targeting neuronal cell-surface proteins. The clinical features of encephalitis are frequently preceded by symptoms suggesting an infectious process, and specific pathogens have been detected at the early phase of the disease in some patients, suggesting that it can be triggered by infections. Moreover, recent data have shown an association with specific HLA haplotypes, suggesting a genetic susceptibility to develop at least some subtypes of autoimmune encephalitis. Nonetheless, the immunological mechanisms leading from an adequate response to infection to autoimmunity against neuronal self-antigens remain highly hypothetical. Molecular mimicry, inborn errors of the host immune system, as well as epitope spreading and chronic activation of innate immunity actors, may be involved. Importantly, the frequency of prodromal infectious symptoms and association with HLA haplotypes differ among autoimmune encephalitides, suggesting that depending on the subtype distinct immunopathogenic mechanisms are involved. A direct link between infection and autoimmune encephalitis was recently provided by the demonstration that most of the so-called relapsing neurological symptoms post-herpes simplex virus encephalitis corresponded to viral-induced autoimmune encephalitis with antibodies against NMDA receptors or other, yet unknown, neuronal surface antigens. Although this association has also been demonstrated experimentally in mice, the underlying immunological mechanisms remain unknown. Overall, a body of clinical, epidemiological and experimental data suggests infections are involved in the pathogenesis of autoimmune encephalitides. Further studies, focusing on the interplays between pathogens, genetic determinants of the host immune response, and brain inflammation, are needed to clarify the immunological mechanisms that lead to autoimmune encephalitis after infection.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Autoimmune encephalitis; Autoimmunity; Herpes virus encephalitis; Post-infectious neurological disorders

Mesh:

Year:  2019        PMID: 31371185     DOI: 10.1016/j.neurol.2019.07.004

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  13 in total

Review 1.  Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection.

Authors:  Wolfgang Löscher; Charles L Howe
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

2.  Risk Prediction Models for Early ICU Admission in Patients With Autoimmune Encephalitis: Integrating Scale-Based Assessments of the Disease Severity.

Authors:  Chunmei Wu; Yongkang Fang; Yingying Zhou; Huiting Wu; Shanshan Huang; Suiqiang Zhu
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

3.  A previously unappreciated polymorphism in the beta chain of I-As expressed in autoimmunity-prone SJL mice: Combined impact on antibody, CD4 T cell recognition and MHC class II dimer structural stability.

Authors:  Katherine A Richards; Courtney Lavery; Grant L J Keller; Jim Miller; Brian M Baker; Andrea J Sant
Journal:  Mol Immunol       Date:  2022-01-05       Impact factor: 4.174

4.  Validation of Predictive Models for Autoimmune Encephalitis-Related Antibodies to Cell-Surface Proteins Expressed in Neurons: A Retrospective Study Based in a Hospital.

Authors:  Siqi Ding; Jiaoni Gong; Jiahe Lin; Yi Wang; Yingjie Hua; Xueying Li; Yanru Du; Niange Xia; Zhenguo Zhu; Xinshi Wang; Rongyuan Zheng; Huiqin Xu
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

Review 5.  Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.

Authors:  Dominique Endres; Frank Leypoldt; Karl Bechter; Alkomiet Hasan; Johann Steiner; Katharina Domschke; Klaus-Peter Wandinger; Peter Falkai; Volker Arolt; Oliver Stich; Sebastian Rauer; Harald Prüss; Ludger Tebartz van Elst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-12       Impact factor: 5.270

Review 6.  NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features.

Authors:  Fabrizio Gardoni; Jennifer Stanic; Diego Scheggia; Alberto Benussi; Barbara Borroni; Monica Di Luca
Journal:  Cells       Date:  2021-01-05       Impact factor: 6.600

Review 7.  Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature.

Authors:  Elizabeth Carroll; Kara R Melmed; Jennifer Frontera; Dimitris G Placantonakis; Steven Galetta; Laura Balcer; Ariane Lewis
Journal:  Seizure       Date:  2021-05-17       Impact factor: 3.414

8.  Assessment of neurological manifestations in hospitalized patients with COVID-19.

Authors:  M Luigetti; R Iorio; A R Bentivoglio; L Tricoli; V Riso; J Marotta; C Piano; G Primiano; L Zileri Del Verme; M R Lo Monaco; P Calabresi
Journal:  Eur J Neurol       Date:  2020-08-24       Impact factor: 6.288

9.  Reversible Parkinsonism caused by Influenza B-associated encephalitis affecting bilateral basal ganglia: A case report.

Authors:  Yue-Li Zhu; Xiao-Ming Guo; Zun-Bo Qin; Zhi-Jian Zhou; Jin Cao; Ji-Min Wu; Jia-Li Pu
Journal:  CNS Neurosci Ther       Date:  2019-12-10       Impact factor: 5.243

10.  Oxidation-Specific Epitopes (OSEs) Dominate the B Cell Response in Murine Polymicrobial Sepsis.

Authors:  Oliver Nicolai; Christian Pötschke; Dina Raafat; Julia van der Linde; Sandra Quosdorf; Anna Laqua; Claus-Dieter Heidecke; Claudia Berek; Murthy N Darisipudi; Christoph J Binder; Barbara M Bröker
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.